{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:31:09Z","timestamp":1759667469036},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11255-020-02730-5","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T12:02:46Z","timestamp":1609675366000},"page":"1383-1389","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum uromodulin levels, MR imaging findings, and their relationship with eGFR-based CKD staging in ADPKD patients"],"prefix":"10.1007","volume":"53","author":[{"given":"Hale Nur","family":"Cansever","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Cevikol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan","family":"Cetinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gultekin","family":"S\u00fcleymanlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"issue":"4","key":"2730_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.5527\/wjn.v4.i4.468","volume":"4","author":"JA Akoh","year":"2015","unstructured":"Akoh JA (2015) Current management of autosomal dominant polycystic kidney disease. World J Nephrol 4(4):468\u2013479","journal-title":"World J Nephrol"},{"issue":"3","key":"2730_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000449394","volume":"2","author":"C Sommerer","year":"2016","unstructured":"Sommerer C, Zeier M (2016) Clinical manifestation and management of ADPKD in Western countries. Kidney Dis (Basel) 2(3):120\u2013127","journal-title":"Kidney Dis (Basel)"},{"key":"2730_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321\u2013337","journal-title":"Annu Rev Med"},{"issue":"5","key":"2730_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.ajkd.2015.06.017","volume":"66","author":"EM Spithoven","year":"2015","unstructured":"Spithoven EM, van Gastel MD, Messchendorp AL et al (2015) Estimation of total kidney volume in autosomal dominant polycystic kidney disease. Am J Kidney Dis 66(5):792\u2013801","journal-title":"Am J Kidney Dis"},{"key":"2730_CR5","doi-asserted-by":"publisher","unstructured":"Tangri N,Hougen I, Alam A, et al. (2017) Total kidney volume as a biomarker of disease progression in autosomal dominant polycystic kidney disease. Can J Kidney Health Dis. https:\/\/doi.org\/10.1177\/2054358117693355","DOI":"10.1177\/2054358117693355"},{"issue":"3","key":"2730_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ et al (2003) Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort1. Kidney Int 64(3):1035\u20131045","journal-title":"Kidney Int"},{"issue":"3","key":"2730_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2215\/CJN.09500911","volume":"7","author":"AB Chapman","year":"2012","unstructured":"Chapman AB, Bost JE, Torres VE et al (2012) Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am SocNephrol. 7(3):479\u2013486","journal-title":"Clin J Am SocNephrol."},{"issue":"2","key":"2730_CR8","first-page":"241","volume":"31","author":"TL Kline","year":"2016","unstructured":"Kline TL, Korfiatis P, Edwards ME et al (2016) Automatic total kidney volume measurement on followup magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression. Nephrol Dial Transpl 31(2):241\u2013248","journal-title":"Nephrol Dial Transpl"},{"key":"2730_CR9","doi-asserted-by":"publisher","unstructured":"Wu TH, Li KJ, Yu CL,\u00a0et al. (2018) Tamm\u2013Horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system. Molecules. 23(1):E200. https:\/\/doi.org\/10.3390\/molecules23010200","DOI":"10.3390\/molecules23010200"},{"issue":"1","key":"2730_CR10","first-page":"5","volume":"15","author":"A Dawnay","year":"1981","unstructured":"Dawnay A, Cattell W (1981) Serum Tamm-Horsfall glycoprotein levels in health and in renal disease. ClinNephrol 15(1):5\u20138","journal-title":"ClinNephrol"},{"issue":"12","key":"2730_CR11","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.ekir.2019.08.010","volume":"4","author":"MR Hanudel","year":"2019","unstructured":"Hanudel MR, Salusky IB, Pereira RC et al (2019) Erythropoietin and fibroblast growth factor 23 in autosomal dominant polycystic kidney disease patients. Kidney Int Rep 4(12):1742\u20131748","journal-title":"Kidney Int Rep"},{"issue":"1","key":"2730_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/HJH.0000000000001527","volume":"36","author":"A Leiherer","year":"2018","unstructured":"Leiherer A, Muendlein A, Saely CH et al (2018) The value of uromodulin as a new serum marker to predict decline in renal function. J Hypertens 36(1):110\u2013118","journal-title":"J Hypertens"},{"issue":"10","key":"2730_CR13","doi-asserted-by":"publisher","first-page":"e3011","DOI":"10.1097\/md.0000000000003011","volume":"95","author":"D Steubl","year":"2016","unstructured":"Steubl D, Block M, Herbst V et al (2016) Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients. Medicine (Baltimore) 95(10):e3011. https:\/\/doi.org\/10.1097\/md.0000000000003011","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"2730_CR14","first-page":"1755","volume":"52","author":"L Risch","year":"2014","unstructured":"Risch L, Lhotta K, Meier D et al (2014) The serum uromodulin level is associated with kidney function. ClinChem Lab Med 52(12):1755\u20131761","journal-title":"ClinChem Lab Med"},{"issue":"5","key":"2730_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1042\/cs0680529","volume":"68","author":"C Thornley","year":"1985","unstructured":"Thornley C, Dawnay A, Cattell W (1985) Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. Clin Sci (Lond) 68(5):529\u2013535","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"2730_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ et al (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26(1):160\u2013172","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2730_CR17","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1681\/ASN.V561349","volume":"5","author":"AB Chapman","year":"1994","unstructured":"Chapman AB, Johnson AM, Gabow PA et al (1994) Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5(6):1349\u20131354","journal-title":"J Am Soc Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02730-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:04:10Z","timestamp":1623330250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02730-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2730"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02730-5","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}